Liposarcoma other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Genetic assessment is one of the other diagnostic test for liposarcoma. | Genetic assessment is one of the other diagnostic test for liposarcoma.<ref name=NCCN>{{cite web | title = NCCN Guidelines for Patients - Soft Tissue Sarcoma | url =http://www.nccn.org/patients/guidelines/sarcoma/index.html#2 }}</ref> | ||
==Other Diagnostic Studies== | ==Other Diagnostic Studies== | ||
Revision as of 21:40, 22 September 2014
|
Liposarcoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Liposarcoma other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Liposarcoma other diagnostic studies |
|
Risk calculators and risk factors for Liposarcoma other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Genetic assessment is one of the other diagnostic test for liposarcoma.[1]
Other Diagnostic Studies
Genetic assessment
The goals, risks and benefit of genetic assessment are numerous. A number of genetic conditions are associated with liposarcoma. Li-Fraumeni syndrome are the most common disease associated with it. The genes for TP53 mutations are tested in the tissue sample to detect Li-Fraumeni syndrome. [1]
References